Abstract
Introduction

Stem cells, characterized by the ability to both self-renew and differentiate into various functional cell types, have been derived from the embryo and various sources of post-natal animals
. [2] [3] [4] [5] [6] [7] . These cells can be differentiated into fibroblasts, adipocytes, osteoblasts, chondrocytes [8] , tendinocytes, ligamentocytes [9] , cardiomyocytes [10] , neuronal cell [11, 12] and other cells [13] . [14] . Myc has generally been associated with the promotion of cellular growth and proliferation, desensitization to growthinhibitory stimuli, blockade of cell differentiation, cellular immortalization and oncogenic transformation [15] . The [16] . MYC proteins are also required for the widespread maintenance of active chromatin [17] . The activation of c-MYC in ESCs induces apoptosis and differentiation into extraembryonic endoderm and trophectoderm lineages while concomitantly reducing expression of POU domain, class5, transcription factor 1 (OCT4) and Nanog homeobox (NANOG) [18] . Myc can positively regulate proliferation in normal cells and cause genomic instability in tumours by controlling DNA replication [19] . However, c-MYC expression does not regulated by RNA exonuclease 1 (REX1), which is critical in proliferation/differentiation of stem cells [20] . The permanent and stable human MSC (hMSC) line generated by transfecting the v-myc gene can be differentiated into neural cell types, including neural stem cells, neurons, astrocytes and oligodendrocytes [21] . Overexpression of c-MYC strongly drives proliferation and growth but also sensitizes cells to apoptosis and senescence [22] . MYC suppresses expression of cell cycle/growth arrest genes gas1, p15, p21, p27 and others, directly, by at least two mechanisms [23] . Decreased c-Myc binding to Sp1 transcriptional complexes in the p21 promoter results in reduced p21 repression [24] .
Mesenchymal stem cells (MSCs) are promising tools for regenerative medicine. MSCs have been isolated from bone marrow, adipose tissue, peripheral blood, foetal liver, lung, amniotic fluid, chorionic villi of the placenta and umbilical cord blood
Myc is a transcription factor of the basic helix-loop-helix-leucine zipper family that can activate or repress gene expression. The c-MYC proto-oncogene has emerged as a critical regulator of cell growth and is one of the genes most frequently altered in cancer
Mammalian [26] . Class I HDACs 1, 2 and 3 interact with components of the p53 and RB tumour-suppressor pathways [27, 28] , suggesting their direct involvement in growth suppression. The overexpression of class I HDACs is well correlated with cancer tissues including stomach, oesophagus, colon, prostate, breast, ovary, lung, pancreas and thyroid [29] . Increased HDAC2 expression is associated with colon cancer depending on the Wnt pathway and c-Myc [30] . The activity of HDAC 1, 2 and 3 inhibits differentiation of ESCs to oligodendrocyte, astrocytes and neurons, respectively [31] . The treatment of HDAC inhibitor suppresses c-MYC expression [32] .
The 
Gene construction and production of lentivirus vectors
The lentivirus was generated using the ViraPower TM Table S1 . 
Cell proliferation and cell cycle analyses
Three days after virus transduction, cells were seeded in 24-well plates and incubated for 2 days. After incubation, 20 l of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) stock solution (5 mg
RT-PCR
Induction of differentiation and statistical analysis
Results
The expression of c-MYC was found in hMSCs and cell proliferation was dramatically decreased after c-MYC knockdown
In this study, c-MYC expression was found in all hMSCs. The c-MYC in the hUCB-MSCs was specifically localized in the nucleus (Fig. 1A) . The RNA and protein expressions of c-MYC were relatively constant through passages (p) of hUCB-MSCs from p3 to p9 (Fig. 1B) . However, the expressions of l-and n-MYC were not constant in hUCB-MSCs throughout the passages (Fig. 1B) . (Fig. 3A) . Figs 3D and 6D) . The localization of p27 is also an important factor for cell growth control [45] and the levels of p27 are high in quiescent cells [46] . Therefore, immuno-cytochemical observation was performed after c-MYC knockdown. In vehiclecontrol infected hUCB-MSCs, the localization of p27 was almost confined in nucleus. However, the signal of p27 in ShM3 (c-MYC knocked-down hUCB-MSCs) was strong and broad, which was distributed not only in the nucleus but also in cytoplasm (Fig. 3E) . (Fig. 6D) . (Fig. 6B-D) . The expressions of other HDACs were not significantly changed after HDAC2 siRNA treatment except for HDAC2 (Fig. 6C) . The down-regulated tumour suppression genes, p27 and p57, in c-MYC overexpressing hUCB-MSCs recovered after the HDAC2 siRNA treatment. However, overexpressed PpRb in c-MYC overexpressing hUCB-MSCs was down-regulated after HDAC2 siRNA treatment (Fig. 6B) . The expression of c-MYC in HDAC2 siRNA treated c-MYC overexpressing hUCB-MSCs was also restored to the normal expression level (Fig. 6B) . (Fig. 7) . (Fig. 8E and F [30, 31] , in accordance to this; in our c-MYC knocked-down study, when HDAC2 is down regulated tumour [50] . Although the expression of c-MYC in adult stem cells has been reported previously [38, 51] (Fig. 6C) .
FACS analysis was performed for the confirmation of hUCB-MSCs (Fig. 1C). Positive markers for hMSCs (CD29, CD44, CD73, CD90 and CD105) were well detected in hUCBMSCs. To validate the function of c-MYC in hMSCs, a c-MYC knockdown experiment was performed with lentivirus vectors in hUCB-MSCs. c-MYC inhibition was confirmed with Western blot and RT-PCR analysis (Fig. 2A). The RNA expressions of cyclindependent kinase inhibitors 1A and 1B (p21 and p27) in c-MYC knocked-down hUCB-MSCs were increased and similar with the vehicle control infected hUCB-MSCs respectively (Fig. 2A). Realtime RT-PCR revealed that the expression of c-MYC was decreased by 60% in ShM1 and 80% in ShM3 lentivirus-infected hUCB-MSCs compared to vehicle control-infected hUCB-MSCs (Fig. 2B). The expressions of n-Myc and l-MYC in hUCB-MSCs were not changed in c-MYC knocked-down hUCB-MSCs (Fig. 2A). The expressions of SOX2 and OCT4 were decreased after c-MYC inhibition of hUCB-MSCs. Cell proliferation was significantly decreased in c-MYC knocked-down hUCB-MSCs compared to vehicle control-infected hUCB-MSCs, which was measured using CPDL (Fig. 2C). The proliferation of c-MYC knockeddown cells decreased continuously from P1 to P3; it was assumed that the proliferation would reduce continuously in following passages too.
Fig. 2 The knockdown of c-MYC results in growth retardation. (A) RNA and protein expression after c-MYC-inhibiting lentivirus infection. Two constructs of c-MYC-inhibiting lentivirus, ShM1 and ShM3, show effective inhibition in hUCB-MSCs. (B) Real-time RT-PCR after c-MYC inhibition in hUCB-MSCs. The expression of c-MYC is decreased by approximately 60% (ShM1) and 80% (ShM3) of the vector control-infected hUCB-MSCs. (C) Cell proliferation is measured with CPDL. c-MYC knocked-down hUCB-MSCs show severe growth retardation. (D) FACS analysis after c-MYC knockdown in hUCB-MSCs. G0/G1 cells are increased in c-MYC knocked-down hUCB-MSCs compared to those of the vehicle control-infected hUCB-MSCs. VC: vehicle control infected hUCB-MSCs. **P Ͻ 0.01.
The cell cycle was arrested in c-MYC knocked-down hUCB-MSCs
The cell cycle was measured in vehicle control-infected and c-MYC knocked-down hUCB-MSCs by FACS analysis (Fig. 2D). The number of cells in the G0/G1 phase was increased in c-MYC knockeddown hUCB-MSCs. Conversely, G2/M phase and S phase cells were decreased in c-MYC knocked-down hUCB-MSCs compared to the vehicle control-infected hUCB-MSCs. The expression of CDK4, which is involved in the control of cell proliferation during the G1 phase [42], was decreased in c-MYC knocked-down hUCB-MSCs compared to that of vehicle control-infected hUCB-MSCs
The protein expressions of p21 and p27, which are G1/S transition inhibitors [43], were increased in c-MYC knocked-down hUCBMSCs compared to the levels in the vehicle control-infected hUCBMSCs (Fig. 3A). The expression of hyperphosphorylated RB (PpRb), which is a G1/S transition accelerator [44], was significantly decreased in c-MYC knocked-down hUCB-MSCs compared to that of vehicle control-infected hUCB-MSCs (Fig. 3A). After c-MYC inhibition of hUCB-MSCs, the expression of class I and class II HDACs were compared at the RNA and protein levels. Among the HDAC family genes, the expressions of HDAC2, HDAC4 and HDAC5 in c-MYC knocked-down hUCB-MSCs were decreased compared to those of vehicle control-infected hUCB-MSCs at RNA expression levels (Fig. 3B and C). The protein expression levels of HDAC2 and HDAC4 were also decreased after c-MYC knockdown in hUCBMSCs (
The overexpression of c-MYC in hUCB-MSCs resulted in growth acceleration and up-regulation of HDAC2
To validate the function of c-MYC in hUCB-MSCs, overexpression study was performed with a lentivirus vector system. The expression of c-MYC was increased 3.5-fold in c-MYC overexpression lentivirusinfected hUCB-MSCs over the vehicle control-infected hUCB-MSCs in real-time RT-PCR analysis (Fig. 4A). These results were confirmed by RT-PCR and Western blot analysis (Fig. 4B). The expressions of SOX2 and OCT4 were increased after c-MYC overexpression of hUCB-MSCs. c-MYC overexpressing hUCB-MSCs grew faster than vehicle control infected hUCB-MSCs, which was measured with MTT assay (Fig. 4C). PpRB expression increased after c-MYC overexpression. The expressions of p21 and p27 were decreased in c-MYC overexpressing hUCB-MSCs compared with those of vehicle controlinfected hUCB-MSCs (Fig. 5A). Among class I and II HDACs, only HDAC2 and HDAC4 expression was significantly increased after c-MYC overexpression in hUCB-MSCs at RNA expression levels (Fig. 5B and C). The increased expression of HDAC2 after c-MYC
overexpression was confirmed at protein level (Fig. 5D). The expressions of other HDAC genes, except HDAC2 and HDAC4, were not significantly changed after c-MYC overexpression in hUCB-MSCs (Fig. 5B-D). However, the protein expression pattern of HDAC4 differed from RNA expression pattern. The protein expression of HDAC4 in c-MYC overexpressing hUCB-MSCs was not increased compared with vehicle control infected hUCB-MSCs
The c-MYC binding site is present in the HDAC2 promoter region and HDAC2 regulation by c-MYC is related to cell growth of hUCB-MSCs
The expression pattern of HDAC2 was matched with that of the c-MYC expression pattern, implying a direct correlation between the expressions of the two genes. After c-MYC knockdown, the expression of HDAC2 was decreased (Figs 3C and 6D). However, the expression of HDAC2 was increased after c-MYC overexpression of hUCB-MSCs (Figs 5B-D and 6B-D). Therefore, we investigated c-MYC binding site to the HDAC2 promoter region. Only one putative c-MYC binding site was found in the HDAC2 promoter region, and c-MYC binding at this site was confirmed in hUCB-MSCs by performing a ChIP assay (Fig. 6A). To evaluate the function of HDAC2 in c-MYC overexpressing hUCB-MSCs, HDAC2 was specifically inhibited with HDAC2 siRNA treatment in c-MYC overexpressing hUCB-MSCs
The accelerated cell proliferation of hUCB-MSCs after c-MYC overexpression was down-regulated after HDAC2 siRNA treatment (data not shown). © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig.4 Overexpression of c-MYC in hUCB-MSCs. (A) c-MYC overexpressing lentivirus-infected hUCB-MSCs (OvM) shows a 3.5-folds increase in expression in real-time RT PCR. (B) RT-PCR and Western blot analysis of c-MYC after c-MYC overexpressing lentivirus-treated hUCB-MSCs. (C) Cell proliferation is enhanced in c-
Differentiation ability was changed after c-MYC expression changes in hUCB-MSCs
The expression of c-MYC in hMSCs can affect stem cell differentiation, directly or indirectly. To evaluate the effect of c-MYC expression in hUCB-MSCs, a differentiation study was performed in c-MYC knocked-down and overexpressed hUCB-MSCs
The influential role of c-MYC in PcG genes expression and the regulation of HDAC2 in hAD-and hBM-MSCs
The expressions of most PcG genes decreased after c-MYC knockdown but increased after c-MYC overexpression in hUCBMSCs (Fig. 8A-C). The increased PcG gene expressions in c-MYC overexpressing hUCB-MSCs were reduced after HDAC2 siRNA treatment, which was a similar pattern in most PcG complexes examined in the RT-PCR results (Fig. 8A-C). A real-time RT-PCR was performed for detailed comparison in subtle changed genes. The expression of EDR2 was down-regulated after c-MYC inhibition and up-regulated after c-MYC overexpression but showed an up-regulation after HDAC2 siRNA treatment in c-MYC overexpressing hUCB-MSCs (Fig. 8D). The expressions of EDR1, RING1 and EZH2 were not down-regulated after HDAC2 inhibition in c-MYC overexpressing hUCB-MSCs. The expression of c-MYC in hAD-MSCs and hBM-MSCs was analysed by Western blot
PcG genes are also important to epigenetic regulation of stem cells [36, 52] , which is affected by c-MYC expression [53] 
Fig. 8 The expressions of PcG gene expression after c-MYC expression changes and c-MYC/HDAC2 expression in hAD-and hBM-MSCs. (A-C) The expression changes of PcG complex genes after c-MYC expression changes with or without HDAC2 siRNA treatment in RT-PCR. Most PcG genes expressions are increased after c-MYC overexpression and reduced after HDAC2 siRNA treatment. (D) Relative gene expression of PcG genes with real-time RT-PCR. PcG gene expressions are positively correlated with c-MYC and HDAC2 expression except of EDR1, EDR2 and RING1 expressions. (E, F) Western blot of c-MYC and HDAC2. (E) The expression pattern of HDAC2 match that of c-MYC expression pattern in hAD-MSCs. (F) The expression of HDAC2 is down-regulated after c-MYC inhibition and up-regulated after c-MYC overexpression in hBM-MSCs. VC: vehicle control infected hMSCs; ShM3: c-MYC knocked-down hMSCs; OvM: c-MYC overexpressing hMSCs.
